[Upadacitinib (rheumatoid arthritis) - Benefit assessment according to §35a Social Code Book V]

Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
Record ID 32018000833
German
Original Title: Upadacitinib (rheumatoide Arthritis) – Nutzenbewertung gemäß § 35a SGB V
Details
Project Status: Completed
Year Published: 2020
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
MeSH Terms
  • Arthritis, Rheumatoid
  • Antirheumatic Agents
  • Janus Kinase Inhibitors
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Im Mediapark, 8, DE-50670 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.